Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00AIO
|
|||
| Drug Name |
Pyridoindole derivative 3
|
|||
| Synonyms |
PMID25656651-Compound-22c
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
UNIVERSITA' DEGLI STUDI DI MILANO-BICOCCA UNIVERSITE DE GENEVE UNIVERSITE CLAUDE BERNARD LYON 1
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C18H14N2O
|
|||
| Canonical SMILES |
COC1=CC=C(C=C1)C2=C3C4=CC=CC=C4NC3=NC=C2
|
|||
| InChI |
1S/C18H14N2O/c1-21-13-8-6-12(7-9-13)14-10-11-19-18-17(14)15-4-2-3-5-16(15)20-18/h2-11H,1H3,(H,19,20)
|
|||
| InChIKey |
PJJCQNCRSXRPLV-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fusion protein Bcr-Abl (Bcr-Abl) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Fusion protein Bcr-Abl (Bcr-Abl) | Target's Patent Info | [1] | |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Bcr-Abl tyrosine kinase inhibitors: a patent review.Expert Opin Ther Pat. 2015 Apr;25(4):397-412. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.